Nanotechnology-based α1-adrenoceptor/gpr55 biomarker assay: molecular prognostic test for aggressive prostate cancer on the horizon?

Patil, K. C. and Daly, C. J. (2017) Nanotechnology-based α1-adrenoceptor/gpr55 biomarker assay: molecular prognostic test for aggressive prostate cancer on the horizon? Socrates Almanac, 2017(8/2), pp. 20-22.

[img] Text
150053.pdf - Accepted Version
Restricted to Repository staff only

303kB

Publisher's URL: http://www.youblisher.com/p/1848669-Socrates-Almanac-Science-Articles-2017-8-2/

Abstract

No abstract available.

Item Type:Articles
Additional Information:Materials of the International Conference 'Excellence in Quality' July 2017, Lucerne, Switzerland.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Daly, Professor Craig
Authors: Patil, K. C., and Daly, C. J.
College/School:College of Medical Veterinary and Life Sciences > School of Life Sciences
Journal Name:Socrates Almanac
Publisher:Europe Business Assembly
ISSN:2053-4736

University Staff: Request a correction | Enlighten Editors: Update this record